Atlas Trials

Safety Study of Allogeneic Mesenchymal Precursor Cell Infusion in Myocardial Infarction

Clinical trial NCT01781390 · COMPLETED

Trial details

NCT number
NCT01781390
Sponsor
Mesoblast, Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Acute Myocardial Infarction
Start date
2013-03-11
Primary completion
2021-04-06
Enrollment
106

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.